Samsara Vision Europe

Did you catch Samsara Vision's CEO and president Tom Ruggia in Pharmaceutical Executive? Tom's thought leadership piece titled, "How to Navigate Global Regulatory Hurdles to Successfully Launch a Medical Device," discusses the need to improve patients' quality of life through innovative medical devices. However, this can only happen if we address global regulatory challenges, Tom explains. He shares Samsara Vision's experience in securing approval and launching the SING IMT®️ in 17 E.U. countries and our work to expand availability across the globe.  The device has helped 300+ patients with AMD regain their independence. Samsara Vision’s first intraocular telescope can reconnect patients with the simple tasks and activities that provide independence and bring joy. Visit our new SING IMT ‘On-Demand’ Portal with the password: SINGIMT. Register here: www.singimt.com #ophthalmology #maculardegeneration #medicaldevice Jason Herod

📣Samsara Vision welcomes Kurt Spiteri Cornish of the Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, UK) to the SING IMT®️ community. Thank you to Dr. Spiteri-Cornish and his team for bringing newfound hope to late-stage AMD patients in the UK. The SING IMT™️ is the only device on the market that helps patients living with late-stage macular degeneration regain their independence. Visit the SING IMT ‘On-Demand’ Portal with the password: SINGIMT. Register here: www.singimt.com

👏Please welcome a new member of the SING IMT®️ Community: Dr. Juan Francisco Santamaria Álvarez of the Institut de la Màcula in Barcelona, Spain. Thank you, Dr. Santamaria, for bringing hope to late-stage AMD patients in Barcelona. The SING IMT™️ is the only device on the market that helps patients living with late-stage macular degeneration regain their independence. Visit the SING IMT ‘On-Demand’ Portal with the password: SINGIMT. Register here: www.singimt.com

Just how much can a patient’s vision improve with the SING IMT™ procedure? This image shows where one patient began on the eye chart, and where she is after the procedure. We are so happy for this patient and her newfound independence. At Samsara Vision, we have a patient-centric approach and we are passionate about helping late-stage AMD patients get back to the things they love to do.  Visit the SING IMT ‘On-Demand’ Portal with the password: SINGIMT. Register here: www.singimt.com #ophthalmology #maculardegeneration Jason Herod

ICYMI, last month Samsara Vision achieved an exciting milestone at ESCRS! We shared a near-live SING IMT®️ surgery. An engaged crowd of hundreds of ophthalmologists watched as MUDr. Pavel Stodůlka, Ph.D., FEBOS-CR performed a SING IMT®️ implant surgery. The near-live surgery gave Samsara Vision the opportunity to show cataract surgeons why they should delay cataract surgery and consider the clinical benefits of SING IMT®️ for patients with cataracts and late-stage AMD. SING IMT®️ provides a gain, on average, of 18 letters vs a traditional IOL of 2.8 letters. This milestone was an incredible way for Samsara Vision to show an impressive group of surgeons their ability to give vision and independence back to a larger number of patients. Jason Herod

👏We are thrilled to welcome Dr. Alessandro Mularoni and Dr. Matteo Forlini from San Marino, to the SING IMT™️ community.    The SING IMT™️ is the only device on the market that helps patients living with late-stage macular degeneration regain their independence. Visit the SING IMT ‘On-Demand’ Portal with the password: SINGIMT. Register here: www.singimt.com   #maculardegeneration #medicaldevice #ophthalmology

A new review published in Eye gives some fresh perspective about the global prevalence of blindness as a result of AMD. According to new data, in 2020: • An estimated 1.85M people globally were blind due to AMD, which ranked as the second leading cause of permanent blindness  • An estimated 6.23M people globally had MSVI as a result of AMD • High-income countries had the highest number of people with AMD-induced blindness, likely as a result of MSVI and AMD being associated with older age Luckily, there is hope for late-stage AMD patients. The SING IMT®️ helps support late-stage AMD patients in regaining their vision so they can be independent and enjoy life again.  Visit our new SING IMT ‘On-Demand’ Portal with the password: SINGIMT. Register here: www.singimt.com #ophthalmology #maculardegeneration #medicaldevice Jason Herod  

We would like to welcome two new surgeons from Poland to the SING IMT®️community: Dr Tomek Chorągiewicz and Dr Joanna Dolar-Szczasny from the University Hospital Lublin. Under the guidance of Prof. Dr. h.c. Robert Rejdak MD, PhD, FICO, the two surgeons each placed a SING IMT®️. According to the surgeons, the procedure is like a cataract surgery and for patients suffering from late-stage AMD a great solution for these patient group to regain their vision. Thank you for joining our community! Jason Herod

👁️ Did you know that nearly 100 surgeons in 17 countries have implanted SING IMT® in over 350 patients? And more than 63 percent of have performed multiple procedures! A few weeks ago, we announced the first SING IMT® (Smaller-Incision New-Generation Implantable Miniature Telescope) patient in China and the acceleration of our global rollout. The SING IMT® is approved for use in patients without previous cataract surgery and 55 years and older in CE Referenced countries and is under investigation in the United States. Read more about our current and future plans for the SING IMT®. Link in comments. Visit our new SING IMT ‘On-Demand’ Portal with the password: SINGIMT. Register here: www.singimt.com #ophthalmology #maculardegeneration #medicaldevice Jason Herod

🎂This year at ESCRS, the organization celebrated the 75th Anniversary of the pivotal first implantation of an intraocular lens by bringing the history of the IOL to life in an exhibit. We are thrilled that ESCRS featured Samsara Vision as part of this exhibit and the SING IMT®️ was at the forefront of the latest technologies available and a validated alternative to cataract surgery. ESCRS recognized the intraocular telescope (SING IMT®️) as a fork in the road in the treatment of patients with cataracts and late-stage AMD. The IOT is now a reality for patients suffering from cataracts and late stage AMD. The European Society of Cataract and Refractive Surgeons (ESCRS) #Ophthalmology #Cataracts #Retina #MacularDegeneration Read more about the 75th Anniversary here: https://lnkd.in/df99u2W9